We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter

Published 2023-07-11

Recommendations

23:17

Moderna Co-Founder and Flagship Pioneering CEO on the Future of Biotech | WSJ News
05:36

Nvidia not overvalued despite low forward P/E and market cap, says DataTrek's Nick Colas
03:13

How OpenAI’s Board Learned About the Launch of ChatGPT
05:26

StemPoint's Michelle Ross talks under-the-radar biotech companies to watch
18:14

Why Rent In NYC Is Out Of Control Right Now
10:06

The Rise And Fall Of Goldman Sachs' Marcus
05:20

Goldman Sachs' Chris Shibutani talks his top biotech picks including Eli Lilly and Pfizer
05:32

Best strategy for investors is to stick with what's working like AI, says Fundstrat's Tom Lee
07:32

Moderna CEO talks skin cancer vaccine: It's a big deal for melanoma patients
04:03

Fundstrat Global Advisors Tom Lee on what and where to buy now at CNBC FA Summit
18:04

How mRNA Medicine Will Change the World | Melissa J. Moore | TED
06:36

The Einstein Of Wall Street Reveals Successes And Failures As NYSE's Most Famous Trader
15:40

CEO Chat with Stéphane Bancel @ Flagship Studio
09:55

СВІТАН: Нищівні УДАРИ по ВОРОГУ: Рознесли БАЗИ окупантів / Масштабні атаки ДРОНІВ по Росії!
11:12

What Makes New York City More Expensive Than London?
24:26

Ken Griffin, Founder and CEO of Citadel
06:18

Moderna CEO Stephane Bancel on melanoma treatment development: A big day for patients
06:28

Large parts of this economy are going to struggle, says Strategic Value Partners' Victor Khosla
05:35

Billionaire investor Ken Langone: Lilly will be the first trillion dollar drug company in history
25:30

Market Cafe With Nilesh Shah | How Should You Invest In A Rallying Market? N18V | CNBC TV18

Similar videos